Patents Assigned to COMPOUND SOLUTIONS, INC.
  • Patent number: 11141442
    Abstract: Tributyrin and/or tributyrin derivatives are used to selectively increase the levels of Bifidobacteria in the gut. In preferred methods, the tributyrin and/or tributyrin derivatives are orally administered alone or in combination with a food item or other nutritionally acceptable carrier, and may further include Bifidobacteria. Tributyrin-enhanced Bifidobacterium strains are also contemplated that include Bifidobacteria previously cultured in tributyrin and/or tributyrin derivatives.
    Type: Grant
    Filed: June 6, 2019
    Date of Patent: October 12, 2021
    Assignee: Compound Solutions, Inc.
    Inventor: Matthew Titlow
  • Patent number: 11045509
    Abstract: Tributyrin and/or tributyrin derivatives are used to selectively increase the levels of Bifidobacteria in the gut. In preferred methods, the tributyrin and/or tributyrin derivatives are orally administered alone or in combination with a food item or other nutritionally acceptable carrier, and may further include Bifidobacteria. Tributyrin-enhanced Bifidobacterium strains are also contemplated that include Bifidobacteria previously cultured in tributyrin and/or tributyrin derivatives.
    Type: Grant
    Filed: July 23, 2019
    Date of Patent: June 29, 2021
    Assignee: COMPOUND SOLUTIONS, INC.
    Inventor: Matthew Titlow